These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 11313767)

  • 21. Familial hypercholesterolemia in St-Petersburg: the known and novel mutations found in the low density lipoprotein receptor gene in Russia.
    Zakharova FM; Damgaard D; Mandelshtam MY; Golubkov VI; Nissen PH; Nilsen GG; Stenderup A; Lipovetsky BM; Konstantinov VO; Denisenko AD; Vasilyev VB; Faergeman O
    BMC Med Genet; 2005 Feb; 6():6. PubMed ID: 15701167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The molecular basis of familial hypercholesterolaemia in Turkish patients.
    Sözen MM; Whittall R; Oner C; Tokatli A; Kalkanoğlu HS; Dursun A; Coşkun T; Oner R; Humphries SE
    Atherosclerosis; 2005 May; 180(1):63-71. PubMed ID: 15823276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of clinical diagnostic criteria for familial hypercholesterolemia genetic testing in Poland.
    Mickiewicz A; Chmara M; Futema M; Fijalkowski M; Chlebus K; Galaska R; Bandurski T; Pajkowski M; Zuk M; Wasag B; Limon J; Rynkiewicz A; Gruchala M
    Atherosclerosis; 2016 Jun; 249():52-8. PubMed ID: 27062410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular genetic testing for familial hypercholesterolemia in the Netherlands: a stepwise screening strategy enhances the mutation detection rate.
    Lombardi MP; Redeker EJ; van Gent DH; Smeele KL; Weerdesteijn R; Mannens MM
    Genet Test; 2006; 10(2):77-84. PubMed ID: 16792510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial defective apolipoprotein B-100: A review.
    Andersen LH; Miserez AR; Ahmad Z; Andersen RL
    J Clin Lipidol; 2016; 10(6):1297-1302. PubMed ID: 27919345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of the frequency and spectrum of mutations recognised to cause familial hypercholesterolaemia in routine clinical practice in a UK specialist hospital lipid clinic.
    Futema M; Whittall RA; Kiley A; Steel LK; Cooper JA; Badmus E; Leigh SE; Karpe F; Neil HA; ; Humphries SE
    Atherosclerosis; 2013 Jul; 229(1):161-8. PubMed ID: 23669246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of a clinically applicable mutation screening technique for genetic diagnosis of familial hypercholesterolemia and familial defective apolipoprotein B.
    Nissen H; Hansen AB; Guldberg P; Hansen TS; Petersen NE; Hørder M
    Clin Genet; 1998 Jun; 53(6):433-9. PubMed ID: 9712531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of phenotypic additive effect of familial defective apolipoprotein B3531 in familial hypercholesterolaemia.
    Giammanco A; Spina R; Fayer F; Barbagallo CM; Noto D; Cefalù AB; Averna MR
    Intern Med J; 2021 Apr; 51(4):585-590. PubMed ID: 33890362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for a third genetic locus causing familial hypercholesterolemia. A non-LDLR, non-APOB kindred.
    Haddad L; Day IN; Hunt S; Williams RR; Humphries SE; Hopkins PN
    J Lipid Res; 1999 Jun; 40(6):1113-22. PubMed ID: 10357843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic heterogeneity of autosomal dominant hypercholesterolemia in Mexico.
    Robles-Osorio L; Huerta-Zepeda A; Ordóñez ML; Canizales-Quinteros S; Díaz-Villaseñor A; Gutiérrez-Aguilar R; Riba L; Huertas-Vázquez A; Rodríguez-Torres M; Gómez-Díaz RA; Salinas S; Ongay-Larios L; Codiz-Huerta G; Mora-Cabrera M; Mehta R; Gómez Pérez FJ; Rull JA; Rabès JP; Tusié-Luna MT; Durán-Vargas S; Aguilar-Salinas CA
    Arch Med Res; 2006 Jan; 37(1):102-8. PubMed ID: 16314194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Common mutations of familial hypercholesterolemia patients in Taiwan: characteristics and implications of migrations from southeast China.
    Chiou KR; Charng MJ
    Gene; 2012 Apr; 498(1):100-6. PubMed ID: 22353362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Familial defective apolipoprotein B-100.
    Hansen PS
    Dan Med Bull; 1998 Sep; 45(4):370-82. PubMed ID: 9777289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular testing for familial hypercholesterolaemia-associated mutations in a UK-based cohort: development of an NGS-based method and comparison with multiplex polymerase chain reaction and oligonucleotide arrays.
    Reiman A; Pandey S; Lloyd KL; Dyer N; Khan M; Crockard M; Latten MJ; Watson TL; Cree IA; Grammatopoulos DK
    Ann Clin Biochem; 2016 Nov; 53(6):654-662. PubMed ID: 26748104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene.
    Wang D; Wu B; Li Y; Heng W; Zhong H; Mu Y; Wang J
    J Hum Genet; 2001; 46(3):152-4. PubMed ID: 11310584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Founder effects facilitate the use of a genotyping-based approach to molecular diagnosis in Swedish patients with familial hypercholesterolaemia.
    Benedek P; Jiao H; Duvefelt K; Skoog T; Linde M; Kiviluoma P; Kere J; Eriksson M; Angelin B
    J Intern Med; 2021 Aug; 290(2):404-415. PubMed ID: 33955087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low frequency of the common Norwegian and Finnish LDL-receptor mutations in Swedish patients with familial hypercholesterolaemia.
    Lind S; Eriksson M; Rystedt E; Wiklund O; Angelin B; Eggertsen G
    J Intern Med; 1998 Jul; 244(1):19-25. PubMed ID: 9698020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Familial defective apolipoprotein B versus familial hypercholesterolemia: an assessment of risk.
    Fouchier SW; Defesche JC; Kastelein JJ; Sijbrands EJ
    Semin Vasc Med; 2004 Aug; 4(3):259-64. PubMed ID: 15630635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Identification and characterization of the first Spanish familial ligand-defective apolipoprotein B homozygote].
    Ejarque I; Civer M; Francisco Ascaso J; Knecht E; Eugenia Armengod M; Carmen R; Tomás Real J; Francisco Chaves J; Javier Martín De Llano J
    Med Clin (Barc); 2001 Feb; 116(4):138-41. PubMed ID: 11222161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of LDL receptor gene mutations and the R3500Q mutation of the apoB gene on lipoprotein phenotype of familial hypercholesterolemic patients from a South European population.
    Real JT; Chaves FJ; Ejarque I; García-García AB; Valldecabres C; Ascaso JF; Armengod ME; Carmena R
    Eur J Hum Genet; 2003 Dec; 11(12):959-65. PubMed ID: 14508510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Limited mutational heterogeneity in the LDLR gene in familial hypercholesterolemia in Tunisia.
    Jelassi A; Jguirim I; Najah M; Abid AM; Boughamoura L; Maatouk F; Rouis M; Boileau C; Rabès JP; Slimane MN; Varret M
    Atherosclerosis; 2009 Apr; 203(2):449-53. PubMed ID: 18757057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.